PharmaShots | Incisive News in 3 Shots

Subscribe Now

Everest

Calliditas Therapeutics Reports the US Regulatory Update on Nefecon for the Treatment of IgA Nephropathy

Calliditas Therapeutics Reports the US Regulatory Update on Nefecon for the Treatment of IgA Nephropathy

August 21, 2023

Everest Licensing Partner Pfizer Presents Results of Etrasimod in P-III (ELEVATE UC 12 & 52) Studies for the Treatment of Ulcerative Colitis at DDW 2022

Everest Licensing Partner Pfizer Presents Results of Etrasimod in P-III (ELEVATE UC 12 & 52) Studies for the Treatment of Ulcerati...

May 25, 2022

Pfizer Report Results of Etrasimod in P-III (ELEVATE UC 52) Study for the Treatment of Ulcerative Colitis

Pfizer Report Results of Etrasimod in P-III (ELEVATE UC 52) Study for the Treatment of Ulcerative Colitis

March 30, 2022

Everest Licensing Partner Venatorx Report Results of Cefepime-Taniborbactam in P-III (CERTAIN-1) Study for Complicated Urinary Tract Infections

Everest Licensing Partner Venatorx Report Results of Cefepime-Taniborbactam in P-III (CERTAIN-1) Study for Complicated Urinary Tra...

March 10, 2022

PharmaShots Weekly Snapshots (September 20 - 24, 2021)

PharmaShots Weekly Snapshots (September 20 - 24, 2021)

September 24, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us